STOCK TITAN

Orthofix Medical Inc. - OFIX STOCK NEWS

Welcome to our dedicated page for Orthofix Medical news (Ticker: OFIX), a resource for investors and traders seeking the latest updates and insights on Orthofix Medical stock.

Orthofix Medical Inc. (NASDAQ: OFIX) is a leading medical device company providing orthopedic and spine solutions to healthcare providers worldwide. Founded in 1980 by orthopedic researcher Giovanni De Bastiani in Verona, Italy, the company has expanded to over 900 employees and operates in the U.S., Italy, Germany, France, the UK, Brazil, Australia, and Puerto Rico. Orthofix's products serve patients in more than 70 countries, focusing on enhancing patient quality of life through innovative medical solutions.

The company is structured into four strategic business units:

  • BioStim: Offering bone growth stimulators using pulsed electromagnetic field technology.
  • Biologics: Providing regenerative tissue products and biological solutions for bone and soft tissue repair.
  • Extremity Fixation: Specializing in devices for fracture repair, deformity correction, and bone reconstruction.
  • Spine Fixation: Delivering comprehensive solutions for spinal implants and bone healing therapies.

Orthofix is committed to clinical research and innovation, continuously introducing new products to meet the evolving needs of the medical community. The company maintains strong partnerships with esteemed institutions like the Texas Scottish Rite Hospital for Children and the Musculoskeletal Transplant Foundation, reflecting its dedication to advancing orthopedic and spine care.

The majority of Orthofix's sales come from its global spine segment, primarily in the United States. The company's products are distributed through sales representatives, distributors, and subsidiaries across North America, Europe, and other international markets. Orthofix's solutions cater to hospitals, physicians, healthcare providers, and patients, aiming to improve treatment outcomes and patient well-being.

Latest News: Stay updated with the latest developments, product launches, and financial reports from Orthofix Medical Inc. to keep track of the company's performance and strategic initiatives.

Rhea-AI Summary
Orthofix Medical announces full commercial launch of 7D FLASH Navigation System Percutaneous Module 2.0
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.23%
Tags
none
-
Rhea-AI Summary
Orthofix Medical Inc. will host an Investor Day at its headquarters on September 20, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.38%
Tags
conferences
-
Rhea-AI Summary
Orthofix Medical Inc. reports Q2 2023 net sales of $187.0 million, a 58% increase YoY. Bone Growth Therapies sees 10% growth, with U.S. spinal implants, biologics, and enabling technologies up 7% YoY. Gross profit increased to $119.6 million, but gross margin decreased to 63.9%. Net loss of $(39.4) million compared to net income of $2.5 million in prior year period. Adjusted EBITDA of $9.9 million, or 5.3% of net sales.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.31%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.25%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.11%
Tags
none

FAQ

What is the current stock price of Orthofix Medical (OFIX)?

The current stock price of Orthofix Medical (OFIX) is $18.91 as of November 22, 2024.

What is the market cap of Orthofix Medical (OFIX)?

The market cap of Orthofix Medical (OFIX) is approximately 712.3M.

What does Orthofix Medical Inc. specialize in?

Orthofix Medical Inc. specializes in orthopedic and spine solutions, offering a range of products for bone growth, fracture repair, and spinal treatments.

Where is Orthofix Medical Inc. headquartered?

Orthofix Medical Inc. is headquartered in the United States with additional locations in Italy, Germany, France, the UK, Brazil, Australia, and Puerto Rico.

What are the main business units of Orthofix?

The main business units are BioStim, Biologics, Extremity Fixation, and Spine Fixation.

How does Orthofix distribute its products?

Orthofix distributes its products through sales representatives, distributors, and subsidiaries across North America, Europe, and other international markets.

What partnerships does Orthofix have?

Orthofix has partnerships with organizations such as the Texas Scottish Rite Hospital for Children and the Musculoskeletal Transplant Foundation.

In how many countries are Orthofix products available?

Orthofix products are available in more than 70 countries around the world.

What segment generates the majority of Orthofix's sales?

The majority of Orthofix's sales come from the global spine segment, particularly in the United States.

What are some key products offered by Orthofix?

Key products include bone growth stimulators, spinal implants, regenerative tissue products, and devices for fracture repair and deformity correction.

How many employees does Orthofix have?

Orthofix has over 900 employees.

When was Orthofix Medical Inc. founded?

Orthofix Medical Inc. was founded in 1980 in Verona, Italy.

Orthofix Medical Inc.

Nasdaq:OFIX

OFIX Rankings

OFIX Stock Data

712.31M
36.31M
4.99%
92.32%
6.57%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
LEWISVILLE